Condition

Neuromyelitis Optica clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Neuromyelitis Optica clinical trials that are recruiting, at sites in 3 countries (most in United States (3), France (1), Germany (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Neuromyelitis Optica clinical trials

StudyPhaseWhereStatusRegistered
Evaluating the effects of ravulizumab in patients with neuromyelitis optica spectrum disorder — Dallas, Texas Recruiting May 3, 2024
Understanding brain lesions in multiple sclerosis and related disorders — New York, New York Recruiting Aug 9, 2023
Digital tool for self-assessing symptoms of Neuromyelitis Optica — Los Angeles, California and 21 other locations Recruiting Oct 4, 2022

All recruiting trials (3)

Related topics

Demyelinating Autoimmune Diseases, CNSMultiple SclerosisRavulizumab

Quick answers

How many Neuromyelitis Optica clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (3 trials), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.